Your selections:
Economic burden of advanced lung cancer patients treated by gefitinib alone and combined with chemotherapy in two regions of China
- Yang, Kehong, Hua, Susan, Wei, Wenting, Yang, Congyan, Zhu, Xinhai, Li, Shu Chuen
Assessment of the quality of pharmacoeconomic evaluation literature in China
- Zhang, Fang, He, Xu, Xiang, Wei, Li, Shu Chuen
- Li, Shu Chuen, Aggarwal, Sanjay Kumar
- Lee, Kenneth K. C., Li, Shu Chuen, Kwong, Kai Sun, Chan, Thomas Y. K., Lee, Vivian W. Y., Lau, Joseph T. F.
Can pharmacoeconomic guidelines be implemented successfully in Asia? (editorial)
Are you sure you would like to clear your session, including search history and login status?